⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL9058812 | 0.96 | — | — | |
| SCHEMBL725415 | 0.82 | LMNA (0.32) | — | |
| SCHEMBL17376990 | 0.80 | LMNA (0.31) | — | |
| SCHEMBL13359184 | 0.79 | — | — | |
| SCHEMBL2587473 | 0.79 | APP (0.37) | — | |
| SCHEMBL6361563 | 0.76 | — | — | |
| SCHEMBL23630669 | 0.75 | LMNA (0.32) | — | |
| SCHEMBL22207814 | 0.74 | TP53 (0.34) | — | |
| SCHEMBL5196723 | 0.71 | — | — | |
| SCHEMBL2478483 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024137805-A1 | NOVEL METHODS FOR TREATING GASTROPARESIS | EVOKE PHARMA, INC (US) | 2024-06-27 | — | — | WO | claimed |
| WO-2024137814-A1 | REDUCTION OF HEALTHCARE RESOURCE UTILIZATION BY PATIENTS TREATED WITH INTRANASALLY-ADMINISTERED METOCLOPRAMIDE | EVOKE PHARMA, INC (US) | 2024-06-27 | — | — | WO | claimed |
| WO-2024053810-A1 | REDOX FLOW BATTERY SYSTEM | 서울과학기술대학교 산학협력단 | 2024-03-14 | — | — | WO | claimed |
| EP-3998932-A1 | ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS | Parsons, C. Lowell (US) | 2022-05-25 | — | — | EP | claimed |
| US-20210307316-A1 | PERFUSION SOLUTION | PERFUSION FLUID TECHNOLOGIES INC (US) | 2021-10-07 | — | — | US | claimed |
| WO-2021011566-A1 | ALKALIZATION OF URINARY BLADDER WALL PRIOR TO TREATMENT WITH INTRAVESICAL HEPARIN AND ALKALINIZED LIDOCAINE TO ENHANCE RELIEF OF BLADDER PAIN SYMPTOMS | PARSONS C LOWELL (US) | 2021-01-21 | — | — | WO | claimed |
| EP-3615053-A1 | PHARMACEUTICAL COMPOSITION COMPRISING TRYPTOPHAN AND PHYLLOKININ DERIVATIVE FOR USE IN TREATING PSYCHIATRIC AND PSYCHOLOGICAL CONDITIONS | Temple Otorongo LLC (US) | 2020-03-04 | — | — | EP | claimed |
| EP-3609483-A1 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | Urigen Pharmaceuticals, Inc. (US) | 2020-02-19 | — | — | EP | claimed |
| EP-3523274-A1 | FORMULATIONS FOR ADMINISTRATION OF EFLORNITHINE | Orbus Therapeutics, Inc. (US) | 2019-08-14 | — | — | EP | claimed |
| WO-2018191412-A9 | ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY | URIGEN PHARMACEUTICALS, INC. (US) | 2019-05-31 | — | — | WO | claimed |
| EP-1740284-A2 | SEPARATIONS PLATFORM BASED UPON ELECTROOSMOSIS-DRIVEN PLANAR CHROMATOGRAPHY | Perkinelmer Las, Inc. (US) | 2007-01-10 | — | — | EP | claimed |
| JP-2006506223-A | — | — | 2006-02-23 | — | — | JP | claimed |
| WO-2005092013-A2 | SEPARATIONS PLATFORM BASED UPON ELECTROOSMOSIS-DRIVEN PLANAR CHROMATOGRAPHY | PERKINELMER LAS, INC. (US) | 2005-10-06 | — | — | WO | claimed |
| EP-1572329-A1 | DEVICE AND METHOD FOR PREPARATORY ELECTROPHORESIS | Bayer Technology Services GmbH (DE) | 2005-09-14 | — | — | EP | claimed |
| WO-2004068511-A2 | FORMATION OF SUPERPARAMAGNETIC PARTICLES | H3 PHARMA INC (CA) | 2004-08-12 | — | — | WO | claimed |
| EP-1436598-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | Meso Scale Technologies LLC (US) | 2004-07-14 | — | — | EP | claimed |
| WO-2004045748-A1 | DEVICE AND METHOD FOR PREPARATORY ELECTROPHORESIS | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2004-06-03 | — | — | WO | claimed |
| WO-2003023380-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES, LLC (US) | 2003-03-20 | — | — | WO | claimed |
| US-6413748-B1 | USING L-PROLINE, 2-KETOGLUTARIC ACID, DIVALENT IRON ION, AND L-PROLINE-3-HYDROXYLASE IN AQUEOUS MEDIUM TO PRODUCE CIS-3-HYDROXY-L-PROLINE | KYOWA HAKKO KOGYO, CO., LTD. (JP) | 2002-07-02 | — | — | US | claimed |
| EP-0271713-A2 | Method for preparing aqueous solutions containing chromogenic materials | SAVYON DIAGNOSTICS LTD. (IL) | 1988-06-22 | — | — | EP | claimed |